Phase I trial of chimeric (human-mouse) monoclonal antibody L6 in patients with non-small-cell lung, colon, and breast cancer
嵌合（人-鼠）单克隆抗体L6治疗非小细胞肺癌、结肠癌和乳腺癌患者的I期临床试验
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/BF01740909
Goodman, G E; Hellstrom, I; Yelton, D E; Murray, J L; O'Hara, S; Meaker, E; Zeigler, L; Palazollo, P; Nicaise, C; Usakewicz, J
